Pain is universal. It disrupts work, time with family, and quality of life. Through innovations, we can make a difference.
Virpax® Pharmaceuticals is collaborating with the best minds of the pharmaceutical industry. Working alongside these leaders, we can improve pain management and target pain at its source.
Partner with us as we develop the next generation of pharmaceutical products that can minimize pain and improve people's lives.
Virpax Pharmaceuticals completed a successful pre-IND Meeting with the US Food and Drug Administration.
Under FDA guidance, Virpax Pharmaceuticals plans to finalize IND and prepare for Phase 1 human study.
Virpax Pharmaceuticals has licensed MedPharm’s topical spray technology to develop a transdermal patch for non-opioid pain management products.
MedPharm Licenses Its MedSpray® ‘Patch-in-a-Can’ Technology to Virpax Pharmaceuticals for Non-Opioid Pain Management Products.
Virpax Pharmaceuticals signs technology license agreement with LipoCure to develop pain management products using its liposome drug delivery products.
Virpax Pharmaceuticals has licensed MedPharm's "Patch-in-a-Can" MedSpray® Technology to develop non-opioid pain management products.